Clinical Trial Update: Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation trial evaluating allogeneic bone marrow–derived mesenchymal stem cells for fistulas in patients with refractory perianal Crohn's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistula

Drugs mentioned

• Allogeneic bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Crohn's Disease, Fistula | Phase 1, Phase 2 | Status: COMPLETED